Join Drs. Goldberg and Yiu as they discuss major themes from the May 2022 ARVO live meeting, including aspects of live meetings vs. virtual, new technologies, gene therapy, and artificial intelligence.

Drs. Goldberg and Yiu discuss advances in studying and treating geographic atrophy, including new data for complement inhibitors, as well as how scientific findings from AVRO might impact current and future retinal care.

What are the details of the COVID-19 vaccine approvals in children under 5? Find out this and more in today's PV Roundup podcast.

Drs. Pieramici and Goldberg discuss the impact of early diagnosis, even before any retinal treatment is necessary, and how it can help patients take steps to improve their systemic disease control. They also discuss the history and advances seen in the treatment, how they individualize therapy including how they educate and motivate patients to adhere to treatment.

Drs. Goldberg and MacCumber discuss the importance of patient support and access in patients who have potentially blinding retinal disease. They discuss how they utilize these programs in their practices, how important these programs help patients get treatment and they share several examples how important it was to preserve these patients' vision.

Should medical schools include gun-related content in their curricula? Find out this and more in today's PV Roundup podcast.

Drs. Pieramici and MacCumber review the clinical data for treating DR with Anti-VEGF treatments and discuss their approaches to different types of patients and how these decisions are informed by these clinical trial data (Protocol W, PANORAMA, etc,).

Drs. Goldberg and Pieramici lay out their parameters of a successful treatment in patients in NPDR and how they rely on anatomic improvement. They discuss which specific diagnostic procedures and their value in different types of patients the most and how often they utilize them.

When will a COVID-19 booster targeting Omicron be available? Find out this and more in today's PV Roundup podcast.

Was the Omicron variant more deadly than Delta? Find out this and more in today's PV Roundup podcast.